Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nandi J Reddy

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 2006
The importance of recognizing whewelliteNandi J Reddy, Arief A Suriawinata, Martin Sedlacek
Clinical Toxicology (Philadelphia, Pa.)|January 4, 2011
Delayed neurological sequelae from ethylene glycol, diethylene glycol and methanol poisoningsNandi J Reddy, Madhuri Sudini, Lionel D Lewis
BMC Cancer|January 8, 2022
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementationKelsey S Lau-Min, Lisa A Varughese, Maria N Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancersNancy L Lewis, Lionel D Lewis, Joseph P Eder, et al.
Cancer Chemotherapy and Pharmacology|November 4, 2017
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancerKevin M Koch, E Claire Dees, Shodeinde A Coker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Effects of food on the relative bioavailability of lapatinib in cancer patientsKevin M Koch, Nandi J Reddy, Roger B Cohen, et al.
Frontiers in Oncology|July 22, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy DosingLisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 2006
The importance of recognizing whewelliteNandi J Reddy, Arief A Suriawinata, Martin Sedlacek
Clinical Toxicology (Philadelphia, Pa.)|January 4, 2011
Delayed neurological sequelae from ethylene glycol, diethylene glycol and methanol poisoningsNandi J Reddy, Madhuri Sudini, Lionel D Lewis
BMC Cancer|January 8, 2022
Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementationKelsey S Lau-Min, Lisa A Varughese, Maria N Nelson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancersNancy L Lewis, Lionel D Lewis, Joseph P Eder, et al.
Cancer Chemotherapy and Pharmacology|November 4, 2017
The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancerKevin M Koch, E Claire Dees, Shodeinde A Coker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Effects of food on the relative bioavailability of lapatinib in cancer patientsKevin M Koch, Nandi J Reddy, Roger B Cohen, et al.
Frontiers in Oncology|July 22, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing <i>DPYD</i> and <i>UGT1A1</i> Screening to Guide Chemotherapy DosingLisa A Varughese, Madhuri Bhupathiraju, Glenda Hoffecker, et al.
Pageof 1